Sign inJoin waitlistJoin the waitlist

Hannah Levavi

Hematology & Oncology · Icahn School of Medicine at Mount Sinai

Credentials: · · ·

History

Icahn School of Medicine At Mount Sinai
Icahn School of Medicine At Mount Sinai
Warren Alpert Medical School at Brown University

Research

Impact of rituximab on COVID-19 outcomes
Annals of Hematology · 2021 · First of 3 authors · Corresponding · 48 citations
Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk
Blood Research · 2022 · 15 citations
JAK inhibitors in the treatment of myelofibrosis
Review · Clinical advances in hematology & oncology · 2022 · First of 3 authors · 12 citations

Bridget Marcellino
4 papers
Douglas Tremblay
4 papers
John Mascarenhas
4 papers
Marina Kremyanskaya
3 papers
Alan Shih
2 papers
Alla Keyzner
2 papers
Jonathan Feld
2 papers
Joseph Tripodi
2 papers
Michal Bar-Natan
2 papers
AS
Amir Steinberg
1 paper
AD
Amy Duffield
1 paper
AK
Anjani Kapadia
1 paper · 1 as a resident

Clinical trials

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2017–2027